ArticlePolymers2025
The Structural Design of a New Graftable Antioxidant and the Theoretical Study of Its Role in the Cross-Linking Reaction Process of Polyethylene.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cross-linked polyethylene (XLPE) insulation is used in most advanced power cable technology. However, in traditional cross-linking, the conductivity of the cross-linking system sharply increases due to the presence of additives (antioxidants and cross-linked agents). Therefore, reducing the number of antioxidants to further reduce conductivity is a very promising method. The structural design of a new dual-functional antioxidant 5-allyloxy-2-hydroxyl-3-tert-butylbenzophenone (5ATB) has been established. The antioxidant behavior and grafting reaction of 5ATB after photocatalysis under ultraviolet (UV) conditions were further studied using density functional theory (DFT). The reaction potential energy information of the six reaction channels at the B3LYP/6-311+G(
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.